By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ultragenyx Pharmaceuticals 

77 Digital Drive
Suite 210
Novato  California  94949  U.S.A.
Phone: 415-884-0223 Fax: 415-884-0562



Company News
Ultragenyx (RARE) Reports Second Quarter 2015 Financial Results And Corporate Update 8/14/2015 10:20:16 AM
Ultragenyx (RARE) To Host Conference Call For Second Quarter 2015 Financial Results And Corporate Update 8/6/2015 10:36:07 AM
Ultragenyx (RARE) Announces Initiation Of Phase II Study Of Recombinant Human Beta-Glucuronidase In Patients Under Five Years Old With Mucopolysaccharidosis 7 8/5/2015 7:20:39 AM
Ultragenyx Pharmaceuticals (RARE) To Present At Upcoming Investor Conferences 8/4/2015 10:25:01 AM
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/22/2015 7:16:04 AM
Ultragenyx Pharmaceuticals (RARE) Appoints John Pinion As Chief Quality Operations Officer And Senior Vice President, Analytical Sciences And Research 7/20/2015 7:21:16 AM
Ultragenyx Pharmaceuticals (RARE) Announces Pricing Of Public Offering Of Common Stock 7/16/2015 7:46:22 AM
Ultragenyx Pharmaceuticals (RARE) Announces Proposed Public Offering Of Common Stock 7/15/2015 7:09:35 AM
Ultragenyx Pharmaceuticals (RARE) Releases Positive Interim 40-Week Bone Treatment Data From Ongoing Pediatric Phase II Study Of KRN23 In X-Linked Hypophosphatemia 7/9/2015 7:19:09 AM
Ultragenyx Pharmaceuticals (RARE) Names Daniel G. Welch As Chairman Of The Board 6/25/2015 7:55:40 AM